Your browser doesn't support javascript.
loading
Stereoselective Pharmacokinetics of Ketamine Administered at a Low Dose in Awake Dogs.
Pargätzi, Gwenda; Bergadano, Alessandra; Spadavecchia, Claudia; Theurillat, Regula; Thormann, Wolfgang; Levionnois, Olivier L.
Afiliação
  • Pargätzi G; Section of Anaesthesiology and Pain Therapy, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
  • Bergadano A; Clinic for Small Animals, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.
  • Spadavecchia C; Section of Occupational Safety, Health Protection and Environmental Safety, Department for Biomedical Research, University of Bern, 3008 Bern, Switzerland.
  • Theurillat R; Section of Anaesthesiology and Pain Therapy, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
  • Thormann W; Institute for Infectious Diseases, University of Bern, 3001 Bern, Switzerland.
  • Levionnois OL; Department of Clinical Chemistry, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
Animals (Basel) ; 14(7)2024 Mar 27.
Article em En | MEDLINE | ID: mdl-38612251
ABSTRACT
The present study aimed to examine the stereoselective pharmacokinetics of racemic ketamine in dogs at low doses. The secondary aims were to identify associated behavioural effects and propose a ketamine infusion rate. The study was conducted on nine intact male beagles, with each dog undergoing two treatments (BOL and INF). For treatment BOL, an intravenous bolus of 1 mg/kg was administered over 2 min. The treatment INF involved an initial bolus of 0.5 mg/kg given over 1 min, followed by an infusion at 0.01 mg/kg/min for 1 h. Blood samples were collected for pharmacokinetic analysis. The median R/S enantiomer ratio of ketamine remained close to 1 throughout the study. Levels of S-norketamine were significantly higher than those of R-norketamine across all time points. Based on the collected data, the infusion rate predicted to achieve a steady-state racemic ketamine plasma concentration of 150 ng/mL was 0.028 mg/kg/min. Higher scores for behavioural effects were observed within the first five minutes following bolus administration. The most common behaviours observed were disorientation, head movements and staring eyes. Furthermore, employing ROC curve analysis, a racemic ketamine plasma concentration of 102 ng/mL was defined as the cut-off value, correlating with the occurrence of undesirable behavioural patterns.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article